J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme07-02-2023
07-02-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors/analysts call with management01-02-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Intimation for (I) Unaudited Financial Results For The Quarter Ended On December 31, 2022; And (Ii)Declaration Of Interim Dividend, If Any, For The Financial Year 2022-23
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve (i) Unaudited financial results for the quarter ended on December 31, 2022; and (ii)Declaration of Interim dividend, if any, for the financial year 2022-2301-02-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 201810-01-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation at JP Morgan Healthcare Conference, SFO US10-01-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Closure of Trading Window
Closure of Trading Window30-12-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).28-12-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BNP Paribas, acting through its Hong Kong branch23-12-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BNP Paribas, acting through its Hong Kong Branch23-12-2022
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 23, 2022 for Tau Investment Holdings Pte Ltd & Tau Holdco Pte Ltd23-12-2022